Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Bet On It: Massachusetts senate quiet since house passed sports betting bill » 14:28
07/30/21
07/30
14:28
07/30/21
14:28
GENI

Genius Sports

$17.02 /

-0.2 (-1.16%)

, ACEL

Accel Entertainment

$11.07 /

-0.11 (-0.98%)

, BALY

Bally's

$49.33 /

+0.06 (+0.12%)

, BYD

Boyd Gaming

$57.08 /

-0.775 (-1.34%)

, CZR

Caesars

$87.76 /

-2.06 (-2.29%)

, CHDN

Churchill Downs

$184.33 /

-2.09 (-1.12%)

, DKNG

DraftKings

$48.38 /

-1.4 (-2.81%)

, PDYPY

Flutter Entertainment

$88.40 /

+0.06 (+0.07%)

, GAN

Gan Limited

$15.16 /

-0.3 (-1.94%)

, LVS

Las Vegas Sands

$42.72 /

-0.28 (-0.65%)

, MGM

MGM Resorts

$37.54 /

-0.65 (-1.70%)

, PENN

Penn National

$68.08 /

-1.51 (-2.17%)

, RSI

Rush Street Interactive

$9.76 /

-0.01 (-0.10%)

, SGMS

Scientific Games

$61.52 /

-0.67 (-1.08%)

, SCR

Score Media

$15.25 /

-0.23 (-1.49%)

, WYNN

Wynn Resorts

$98.99 /

-0.81 (-0.81%)

Welcome to the latest…

ShowHide Related Items >><<
WYNN Wynn Resorts
$98.99 /

-0.81 (-0.81%)

SGMS Scientific Games
$61.52 /

-0.67 (-1.08%)

RSI Rush Street Interactive
$9.76 /

-0.01 (-0.10%)

PENN Penn National
$68.08 /

-1.51 (-2.17%)

PDYPY Flutter Entertainment
$88.40 /

+0.06 (+0.07%)

MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

LVS Las Vegas Sands
$42.72 /

-0.28 (-0.65%)

GENI Genius Sports
$17.02 /

-0.2 (-1.16%)

GAN Gan Limited
$15.16 /

-0.3 (-1.94%)

DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

CZR Caesars
$87.76 /

-2.06 (-2.29%)

CHDN Churchill Downs
$184.33 /

-2.09 (-1.12%)

BYD Boyd Gaming
$57.08 /

-0.775 (-1.34%)

BALY Bally's
$49.33 /

+0.06 (+0.12%)

ACEL Accel Entertainment
$11.07 /

-0.11 (-0.98%)

GENI Genius Sports
$17.02 /

-0.2 (-1.16%)

07/28/21 Goldman Sachs
Genius Sports price target lowered to $29 from $31 at Goldman Sachs
06/07/21
Fly Intel: Top five analyst initiations
06/07/21 Needham
Genius Sports initiated with a Buy at Needham
06/02/21 Goldman Sachs
Genius Sports initiated with a Buy at Goldman Sachs
ACEL Accel Entertainment
$11.07 /

-0.11 (-0.98%)

06/03/21 Macquarie
Accel Entertainment price target raised to $14 from $13 at Macquarie
05/12/21 Northland
Accel Entertainment price target raised to $20 from $15 at Northland
05/12/21 Deutsche Bank
Accel Entertainment price target raised to $14 from $13 at Deutsche Bank
04/08/21 JPMorgan
Accel Entertainment initiated with an Overweight at JPMorgan
BALY Bally's
$49.33 /

+0.06 (+0.12%)

06/28/21 Stifel
Bally's price target raised to $81 from $75 at Stifel
04/27/21 Truist
Red Rock Resorts price target raised to $42 from $34 at Truist
04/27/21 Truist
MGM Resorts price target raised to $43 from $38 at Truist
04/27/21 Truist
Monarch Casino price target raised to $77 from $70 at Truist
BYD Boyd Gaming
$57.08 /

-0.775 (-1.34%)

07/28/21 Stifel
Boyd Gaming price target raised to $88 from $82 at Stifel
07/28/21 Truist
Boyd Gaming price target raised to $87 from $73 at Truist
04/28/21 Deutsche Bank
Boyd Gaming price target raised to $77 from $71 at Deutsche Bank
04/27/21 Truist
Boyd Gaming price target raised to $78 from $65 at Truist
CZR Caesars
$87.76 /

-2.06 (-2.29%)

06/10/21 JPMorgan
Caesars price target raised to $129 from $120 at JPMorgan
06/07/21 Deutsche Bank
Caesars price target raised to $132 from $126 at Deutsche Bank
05/06/21 KeyBanc
Caesars price target raised to $125 from $110 at KeyBanc
05/05/21 Deutsche Bank
Caesars price target raised to $126 from $120 at Deutsche Bank
CHDN Churchill Downs
$184.33 /

-2.09 (-1.12%)

08:08 Today Jefferies
Churchill Downs price target raised to $254 from $244 at Jefferies
06/18/21
Fly Intel: Top five analyst initiations
06/18/21 Macquarie
Macquarie starts Churchill Downs at Outperform on racing machine growth
06/17/21 Macquarie
Churchill Downs initiated with an Outperform at Macquarie
DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

07/28/21 Goldman Sachs
DraftKings price target lowered to $73 from $77 at Goldman Sachs
07/21/21 Needham
Needham sees NFT marketplace entrance as interesting call option for DraftKings
07/21/21 Craig-Hallum
Craig-Hallum bullish on DraftKings NFT marketplace, partnership with Autograph
06/25/21 Northland
DraftKings views risks in recent short report as 'irrelevant,' says Northland
PDYPY Flutter Entertainment
$88.40 /

+0.06 (+0.07%)

07/28/21 Citi
Flutter Entertainment price target raised to 11,700 GBp at Citi
07/28/21 Peel Hunt
Flutter Entertainment upgraded to Buy from Reduce at Peel Hunt
07/27/21 JPMorgan
Flutter Entertainment upgraded to Overweight from Neutral at JPMorgan
07/22/21 RBC Capital
Flutter Entertainment upgraded to Outperform from Sector Perform at RBC Capital
GAN Gan Limited
$15.16 /

-0.3 (-1.94%)

05/24/21 B. Riley
Gan Limited transferred with Buy, $26 target at B. Riley
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
03/26/21
Fly Intel: Top five analyst downgrades
LVS Las Vegas Sands
$42.72 /

-0.28 (-0.65%)

07/22/21 Stifel
Las Vegas Sands price target lowered to $65 from $77 at Stifel
04/22/21 Credit Suisse
Las Vegas Sands price target raised to $69 from $58 at Credit Suisse
04/20/21 JPMorgan
Las Vegas Sands should be bought ahead of sentiment turn, says JPMorgan
04/19/21 Jefferies
Las Vegas Sands price target raised to $71 from $66 at Jefferies
MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
PENN Penn National
$68.08 /

-1.51 (-2.17%)

07/28/21 Goldman Sachs
Penn National price target lowered to $124 from $149 at Goldman Sachs
05/07/21 Morgan Stanley
Penn National selloff 'feels overdone' after 'strong' Q1, says Morgan Stanley
05/06/21 Stifel
Stifel wouldn't expect Penn National Q1 beat to drive shares 'materially higher'
04/26/21 Needham
Penn National initiated with a Buy at Needham
RSI Rush Street Interactive
$9.76 /

-0.01 (-0.10%)

07/28/21 Goldman Sachs
Rush Street Interactive price target lowered to $17 from $18 at Goldman Sachs
05/14/21 Benchmark
Rush Street Interactive price target lowered to $25 from $34 at Benchmark
04/26/21 Needham
Rush Street Interactive initiated with a Buy at Needham
04/16/21
Fly Intel: Top five analyst initiations
SGMS Scientific Games
$61.52 /

-0.67 (-1.08%)

07/20/21 Craig-Hallum
SciPlay downgraded to Hold from Buy at Craig-Hallum
07/16/21 Stifel
SciPlay downgraded to Hold from Buy at Stifel
07/16/21 Truist
SciPlay downgraded to Hold from Buy at Truist
07/01/21 Macquarie
Scientific Games divestiture positive for International Game, says Macquarie
SCR Score Media
$15.25 /

-0.23 (-1.49%)

06/30/21
Fly Intel: Top five analyst initiations
06/30/21 Morgan Stanley
Score Media initiated with an Equal Weight at Morgan Stanley
06/23/21 Credit Suisse
Score Media 'biggest winner' from C-218 passing, says Credit Suisse
06/22/21 Credit Suisse
Score Media rallies with Credit Suisse positive ahead of sports betting vote
WYNN Wynn Resorts
$98.99 /

-0.81 (-0.81%)

07/28/21 Goldman Sachs
Wynn Resorts price target lowered to $110 from $116 at Goldman Sachs
05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
WYNN Wynn Resorts
$98.99 /

-0.81 (-0.81%)

SGMS Scientific Games
$61.52 /

-0.67 (-1.08%)

RSI Rush Street Interactive
$9.76 /

-0.01 (-0.10%)

PENN Penn National
$68.08 /

-1.51 (-2.17%)

MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

LVS Las Vegas Sands
$42.72 /

-0.28 (-0.65%)

GAN Gan Limited
$15.16 /

-0.3 (-1.94%)

DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

CZR Caesars
$87.76 /

-2.06 (-2.29%)

CHDN Churchill Downs
$184.33 /

-2.09 (-1.12%)

BYD Boyd Gaming
$57.08 /

-0.775 (-1.34%)

BALY Bally's
$49.33 /

+0.06 (+0.12%)

ACEL Accel Entertainment
$11.07 /

-0.11 (-0.98%)

  • 10
    Jun
  • 16
    Apr
  • 25
    Feb
  • 09
    Feb
  • 17
    Dec
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 24
    Sep
WYNN Wynn Resorts
$98.99 /

-0.81 (-0.81%)

SCR Score Media
$15.25 /

-0.23 (-1.49%)

PENN Penn National
$68.08 /

-1.51 (-2.17%)

PDYPY Flutter Entertainment
$88.40 /

+0.06 (+0.07%)

MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

BYD Boyd Gaming
$57.08 /

-0.775 (-1.34%)

BALY Bally's
$49.33 /

+0.06 (+0.12%)

SGMS Scientific Games
$61.52 /

-0.67 (-1.08%)

MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

LVS Las Vegas Sands
$42.72 /

-0.28 (-0.65%)

GENI Genius Sports
$17.02 /

-0.2 (-1.16%)

GAN Gan Limited
$15.16 /

-0.3 (-1.94%)

DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

CHDN Churchill Downs
$184.33 /

-2.09 (-1.12%)

BYD Boyd Gaming
$57.08 /

-0.775 (-1.34%)

BALY Bally's
$49.33 /

+0.06 (+0.12%)

WYNN Wynn Resorts
$98.99 /

-0.81 (-0.81%)

SGMS Scientific Games
$61.52 /

-0.67 (-1.08%)

SCR Score Media
$15.25 /

-0.23 (-1.49%)

RSI Rush Street Interactive
$9.76 /

-0.01 (-0.10%)

PENN Penn National
$68.08 /

-1.51 (-2.17%)

MGM MGM Resorts
$37.54 /

-0.65 (-1.70%)

LVS Las Vegas Sands
$42.72 /

-0.28 (-0.65%)

GENI Genius Sports
$17.02 /

-0.2 (-1.16%)

GAN Gan Limited
$15.16 /

-0.3 (-1.94%)

DKNG DraftKings
$48.38 /

-1.4 (-2.81%)

CZR Caesars
$87.76 /

-2.06 (-2.29%)

Options
Marin Software call volume above normal and directionally bullish » 12:45
07/30/21
07/30
12:45
07/30/21
12:45
MRIN

Marin Software

$8.45 /

+1.98 (+30.60%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRIN Marin Software
$8.45 /

+1.98 (+30.60%)

MRIN Marin Software
$8.45 /

+1.98 (+30.60%)

MRIN Marin Software
$8.45 /

+1.98 (+30.60%)

Yesterday
Hot Stocks
Biogen, Eisai announce trial design for ICARE AD-US trial » 17:16
07/29/21
07/29
17:16
07/29/21
17:16
BIIB

Biogen

$329.41 /

-5.12 (-1.53%)

, ESALY

Eisai

$85.30 /

+0.35 (+0.41%)

Biogen (BIIB) and Eisai…

Biogen (BIIB) and Eisai (ESALY) announced that it led a late-breaking presentation on the design of the first real-world observational Phase 4 study in Alzheimer's disease called ICARE AD-US, at the Alzheimer's Association International Conference, or AAIC. ICARE AD-US, a prospective study of Aduhelm 100 mg/mL solution for injection, is designed to collect real-world, long-term effectiveness and safety data on Aduhelm. Aduhelm is indicated for the treatment of Alzheimer's disease. Treatment with Aduhelm should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in clinical trials. There are no safety or effectiveness data on initiating treatment at earlier or later stages of the disease than were studied. This indication is approved under accelerated approval based on reduction in amyloid beta plaques observed in patients treated with Aduhelm. Continued approval for this indication may be contingent upon verification of clinical benefit in confirmatory trials. ICARE AD-US is a study that will provide information on the long-term effectiveness and safety of Aduhelm as prescribed in routine clinical practice in the U.S. based on the label approved by the FDA. The primary objective of the study is to characterize and evaluate changes in cognition, function and neuropsychiatric status in Aduhelm-treated patients. Secondary objectives are related to gaining a better understanding of Aduhelm safety in clinical practice. The study design includes an important goal to help address the common underrepresentation of Black/African American and Latinx patients in Alzheimer's disease studies, aiming to enroll at least 16% of the trial's expected 6,000 participants from these communities. The study intends to enroll patients with Alzheimer's disease over four years from approximately 200 sites in the U.S. Patients will be monitored for a period of up to five years.

ShowHide Related Items >><<
ESALY Eisai
$85.30 /

+0.35 (+0.41%)

BIIB Biogen
$329.41 /

-5.12 (-1.53%)

BIIB Biogen
$329.41 /

-5.12 (-1.53%)

07/27/21 Canaccord
Biogen price target raised to $423 from $359 at Canaccord
07/27/21 Cantor Fitzgerald
Biogen price target lowered to $427 from $435 at Cantor Fitzgerald
07/26/21 Stifel
Acumen initiated with a Buy at Stifel
07/23/21 RBC Capital
Biogen price target lowered to $341 from $361 at RBC Capital
ESALY Eisai
$85.30 /

+0.35 (+0.41%)

06/25/21 Morgan Stanley
Eisai downgraded to Equal Weight from Overweight at Morgan Stanley
06/17/21 JPMorgan
Eisai upgraded to Overweight from Neutral at JPMorgan
01/20/21 William Blair
Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
11/05/20 Jefferies
Eisai upgraded to Buy from Hold at Jefferies
BIIB Biogen
$329.41 /

-5.12 (-1.53%)

BIIB Biogen
$329.41 /

-5.12 (-1.53%)

ESALY Eisai
$85.30 /

+0.35 (+0.41%)

BIIB Biogen
$329.41 /

-5.12 (-1.53%)

BIIB Biogen
$329.41 /

-5.12 (-1.53%)

Hot Stocks
Lilly reports donanemab led to 24% lowering of P-tau217 from baseline in study » 15:04
07/29/21
07/29
15:04
07/29/21
15:04
LLY

Eli Lilly

$244.57 /

-2.04 (-0.83%)

At the Alzheimer's…

At the Alzheimer's Association International Conference, Eli Lilly presented two new exploratory analyses of data from the Phase 2 TRAILBLAZER-ALZ study. In the first, greater amyloid plaque changes following donanemab treatment was highly associated with less cognitive decline and participants with greater plaque clearance at 24 weeks of treatment showed less tau progression. In the second, Lilly shared data showing that treatment with donanemab drives a rapid reduction of a biomarker reflecting Alzheimer's disease pathology, plasma P-tau217, which was detected within 12 weeks. Donanemab is an investigational antibody that targets a modified form of beta amyloid plaque called N3pG. In June 2021, Lilly announced the U.S. Food and Drug Administration had granted Breakthrough Therapy designation for donanemab based on the Phase 2 data. No additional safety analyses were performed related to the presentations. In the first oral presentation, donanemab induced rapid amyloid plaque reduction at 24 weeks in participants with early symptomatic AD, with the most rapid clearance in subjects with the most severe plaque burden at baseline. The subset of participants who reached complete amyloid plaque clearance at 24 weeks were able to stop or reduce dosing of donanemab earlier than other patients. Among those who achieved complete amyloid plaque clearance at 24 weeks and had a blinded switch to placebo, an exposure-response model showed minimal amyloid re-accumulation over the next year. Additionally, among those who reached early complete amyloid plaque clearance status at 24 weeks, a flortaucipir positron emission tomography scan at 76 weeks showed a significant decrease of tau spread - a predictive biomarker for AD progression - over 76 weeks in frontal, parietal and temporal brain regions compared to placebo. Greater amyloid plaque change at 24 weeks was also associated with improved Integrated Alzheimer's Disease Rating Scale score, a validated, composite measure that combines two well-established instruments used to assess cognition and daily function in AD clinical trials. Additionally, pharmacokinetic/pharmacodynamic modeling showed that greater relative amyloid plaque clearance was correlated with greater clinical benefit. A second oral presentation focused on plasma P-tau217, a research blood-biomarker developed by Lilly, associated with amyloid and tau pathology and diagnosis of Alzheimer's disease. Planned analyses showed that treatment with donanemab resulted in early reduction of P-tau217 and showed significant reduction by the 3-month timepoint compared to placebo. Decreased P-tau217 correlated significantly with amyloid change at all timepoints, at 24 weeks and 76 weeks, the company said.

ShowHide Related Items >><<
LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Stifel
Acumen initiated with a Buy at Stifel
07/19/21 Goldman Sachs
Option Care Health upgraded to Buy from Neutral at Goldman Sachs
LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

LLY Eli Lilly
$244.57 /

-2.04 (-0.83%)

Options
Unusually active option classes on open July 29th » 09:40
07/29/21
07/29
09:40
07/29/21
09:40
LODE

Comstock Mining

$3.01 /

+ (+0.00%)

, ING

ING Groep

$12.76 /

+ (+0.00%)

, VXRT

Vaxart

$8.20 /

+ (+0.00%)

, ZM

Zoom Video

$369.42 /

+0.06 (+0.02%)

, NOK

Nokia

$5.81 /

+ (+0.00%)

, HPQ

HP Inc.

$28.48 /

+ (+0.00%)

, BUD

AB InBev

$68.62 /

+ (+0.00%)

, MGM

MGM Resorts

$38.40 /

+ (+0.00%)

, UBER

Uber

$46.14 /

+0.01 (+0.02%)

Unusual total active…

Unusual total active option classes on open include: Comstock Mining (LODE), ING Group (ING), Royal Dutch Shell (RDS/A), Vaxart (VXRT), Zoom Video Communications (ZM), Nokia (NOK), HP Inc. (HPQ), Anheuser Busch (BUD), MGM Resorts (MGM), and Uber (UBER).

ShowHide Related Items >><<
ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

VXRT Vaxart
$8.20 /

+ (+0.00%)

UBER Uber
$46.14 /

+0.01 (+0.02%)

NOK Nokia
$5.81 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+ (+0.00%)

LODE Comstock Mining
$3.01 /

+ (+0.00%)

ING ING Groep
$12.76 /

+ (+0.00%)

HPQ HP Inc.
$28.48 /

+ (+0.00%)

BUD AB InBev
$68.62 /

+ (+0.00%)

LODE Comstock Mining
$3.01 /

+ (+0.00%)

ING ING Groep
$12.76 /

+ (+0.00%)

07/09/21 UBS
ING Groep price target raised to EUR 12 from EUR 11.70 at UBS
07/08/21 JPMorgan
ING Groep price target raised to EUR 12.40 from EUR 12 at JPMorgan
06/22/21 Kepler Cheuvreux
Kepler Cheuvreux downgrades European banks to Neutral from Overweight
06/04/21 Barclays
ING Groep downgraded to Underweight from Equal Weight at Barclays
VXRT Vaxart
$8.20 /

+ (+0.00%)

06/30/21
Fly Intel: Top five analyst downgrades
06/30/21 B. Riley
B. Riley downgraded Vaxart to Neutral on 'riskier development path'
06/29/21 B. Riley
Vaxart downgraded to Neutral from Buy at B. Riley
06/24/21 Jefferies
Vaxart initiated with a Buy at Jefferies
ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

07/29/21 KeyBanc
KeyBanc upgrades Zoom with $428 target on 'future hybrid work state'
07/29/21 KeyBanc
Zoom Video upgraded to Overweight from Sector Weight at KeyBanc
07/28/21 Piper Sandler
Five9 downgraded to Neutral from Overweight at Piper Sandler
07/27/21 Jefferies
Five9 downgraded to Hold from Buy at Jefferies
NOK Nokia
$5.81 /

+ (+0.00%)

07/14/21
Fly Intel: Top five analyst upgrades
07/14/21 JPMorgan
JPMorgan upgrades Nokia on 'more room to run' for mobile turnaround
07/13/21 JPMorgan
Nokia upgraded to Overweight from Neutral at JPMorgan
07/12/21 Barclays
Nokia price target raised to EUR 4.50 from EUR 4.25 at Barclays
HPQ HP Inc.
$28.48 /

+ (+0.00%)

07/02/21 Bernstein
HP plus Xerox 'consolidation math compelling,' says Bernstein
05/28/21 Morgan Stanley
HP Inc. post-earnings pullback a buying opportunity, says Morgan Stanley
05/28/21 Citi
Citi says HP is not at peak, reiterates Buy rating
05/28/21 Deutsche Bank
HP Inc. price target raised to $32 from $30 at Deutsche Bank
BUD AB InBev
$68.62 /

+ (+0.00%)

07/15/21 Barclays
AB InBev price target raised to EUR 75 from EUR 74 at Barclays
07/07/21 Deutsche Bank
AB InBev price target raised to EUR 62 from EUR 59 at Deutsche Bank
07/07/21 JPMorgan
AB InBev price target raised to EUR 65 from EUR 55 at JPMorgan
07/07/21 UBS
AB InBev price target raised to EUR 63 from EUR 61 at UBS
MGM MGM Resorts
$38.40 /

+ (+0.00%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
UBER Uber
$46.14 /

+0.01 (+0.02%)

07/22/21 Stifel
Acquisition of Transplace expands Uber Freight's capabilities, says Stifel
07/21/21 DA Davidson
HyreCar initiated with a Buy at DA Davidson
07/01/21 Cowen
Uber target raised to $80 on rising mobility users at Cowen
07/01/21 Arete
Uber upgraded to Neutral from Sell at Arete
ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

VXRT Vaxart
$8.20 /

+ (+0.00%)

UBER Uber
$46.14 /

+0.01 (+0.02%)

NOK Nokia
$5.81 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+ (+0.00%)

ING ING Groep
$12.76 /

+ (+0.00%)

HPQ HP Inc.
$28.48 /

+ (+0.00%)

BUD AB InBev
$68.62 /

+ (+0.00%)

  • 29
    Jul
  • 13
    Jan
  • 08
    Jan
ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

VXRT Vaxart
$8.20 /

+ (+0.00%)

UBER Uber
$46.14 /

+0.01 (+0.02%)

NOK Nokia
$5.81 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+ (+0.00%)

LODE Comstock Mining
$3.01 /

+ (+0.00%)

ING ING Groep
$12.76 /

+ (+0.00%)

HPQ HP Inc.
$28.48 /

+ (+0.00%)

BUD AB InBev
$68.62 /

+ (+0.00%)

ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

VXRT Vaxart
$8.20 /

+ (+0.00%)

UBER Uber
$46.14 /

+0.01 (+0.02%)

NOK Nokia
$5.81 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+ (+0.00%)

LODE Comstock Mining
$3.01 /

+ (+0.00%)

HPQ HP Inc.
$28.48 /

+ (+0.00%)

BUD AB InBev
$68.62 /

+ (+0.00%)

ZM Zoom Video
$369.42 /

+0.06 (+0.02%)

VXRT Vaxart
$8.20 /

+ (+0.00%)

UBER Uber
$46.14 /

+0.01 (+0.02%)

NOK Nokia
$5.81 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+ (+0.00%)

LODE Comstock Mining
$3.01 /

+ (+0.00%)

HPQ HP Inc.
$28.48 /

+ (+0.00%)

BUD AB InBev
$68.62 /

+ (+0.00%)

Hot Stocks
Nevada reports June statewide gaming win up 110.5% to $1.19B » 09:33
07/29/21
07/29
09:33
07/29/21
09:33
BYD

Boyd Gaming

$58.55 /

+1.66 (+2.92%)

, MGM

MGM Resorts

$38.40 /

+0.37 (+0.97%)

, CZR

Caesars

$92.54 /

+0.04 (+0.04%)

, CHDN

Churchill Downs

$188.06 /

-0.72 (-0.38%)

, PENN

Penn National

$72.06 /

+0.3 (+0.42%)

, WYNN

Wynn Resorts

$102.16 /

+1.83 (+1.82%)

, LVS

Las Vegas Sands

$44.50 /

+0.88 (+2.02%)

, GAN

Gan Limited

$16.15 /

+0.39 (+2.47%)

, PDYPY

Flutter Entertainment

$88.34 /

+0.89 (+1.02%)

, WIMHY

William Hill

$15.00 /

+ (+0.00%)

, DKNG

DraftKings

$50.63 /

+1.87 (+3.84%)

Nevada reports June Las…

Nevada reports June Las Vegas Strip gaming win up 156.3% compared to 2020 to $610.56M. Publicly traded companies in the space casino include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (PDYPY), Gan Limited (GAN), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN), William Hill (WIMHY) and Wynn Resorts (WYNN).

ShowHide Related Items >><<
WYNN Wynn Resorts
$102.16 /

+1.83 (+1.82%)

PENN Penn National
$72.06 /

+0.3 (+0.42%)

PDYPY Flutter Entertainment
$88.34 /

+0.89 (+1.02%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

LVS Las Vegas Sands
$44.50 /

+0.88 (+2.02%)

GAN Gan Limited
$16.15 /

+0.39 (+2.47%)

DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

CZR Caesars
$92.54 /

+0.04 (+0.04%)

CHDN Churchill Downs
$188.06 /

-0.72 (-0.38%)

BYD Boyd Gaming
$58.55 /

+1.66 (+2.92%)

BYD Boyd Gaming
$58.55 /

+1.66 (+2.92%)

07/28/21 Stifel
Boyd Gaming price target raised to $88 from $82 at Stifel
07/28/21 Truist
Boyd Gaming price target raised to $87 from $73 at Truist
04/28/21 Deutsche Bank
Boyd Gaming price target raised to $77 from $71 at Deutsche Bank
04/27/21 Truist
Boyd Gaming price target raised to $78 from $65 at Truist
MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
CZR Caesars
$92.54 /

+0.04 (+0.04%)

06/10/21 JPMorgan
Caesars price target raised to $129 from $120 at JPMorgan
06/07/21 Deutsche Bank
Caesars price target raised to $132 from $126 at Deutsche Bank
05/06/21 KeyBanc
Caesars price target raised to $125 from $110 at KeyBanc
05/05/21 Deutsche Bank
Caesars price target raised to $126 from $120 at Deutsche Bank
CHDN Churchill Downs
$188.06 /

-0.72 (-0.38%)

06/18/21
Fly Intel: Top five analyst initiations
06/18/21 Macquarie
Macquarie starts Churchill Downs at Outperform on racing machine growth
06/17/21 Macquarie
Churchill Downs initiated with an Outperform at Macquarie
05/14/21
Fly Intel: Top five analyst upgrades
PENN Penn National
$72.06 /

+0.3 (+0.42%)

07/28/21 Goldman Sachs
Penn National price target lowered to $124 from $149 at Goldman Sachs
05/07/21 Morgan Stanley
Penn National selloff 'feels overdone' after 'strong' Q1, says Morgan Stanley
05/06/21 Stifel
Stifel wouldn't expect Penn National Q1 beat to drive shares 'materially higher'
04/26/21 Needham
Penn National initiated with a Buy at Needham
WYNN Wynn Resorts
$102.16 /

+1.83 (+1.82%)

07/28/21 Goldman Sachs
Wynn Resorts price target lowered to $110 from $116 at Goldman Sachs
05/11/21 Morgan Stanley
Wynn Resorts price target raised to $145 from $140 at Morgan Stanley
05/11/21 Citi
Citi upgrades Wynn Resorts to Neutral on 'value-enhancing' deal
05/11/21 Citi
Wynn Resorts upgraded to Neutral from Sell at Citi
LVS Las Vegas Sands
$44.50 /

+0.88 (+2.02%)

07/22/21 Stifel
Las Vegas Sands price target lowered to $65 from $77 at Stifel
04/22/21 Credit Suisse
Las Vegas Sands price target raised to $69 from $58 at Credit Suisse
04/20/21 JPMorgan
Las Vegas Sands should be bought ahead of sentiment turn, says JPMorgan
04/19/21 Jefferies
Las Vegas Sands price target raised to $71 from $66 at Jefferies
GAN Gan Limited
$16.15 /

+0.39 (+2.47%)

05/24/21 B. Riley
Gan Limited transferred with Buy, $26 target at B. Riley
04/07/21 Truist
Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud'
04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
03/26/21
Fly Intel: Top five analyst downgrades
PDYPY Flutter Entertainment
$88.34 /

+0.89 (+1.02%)

07/28/21 Citi
Flutter Entertainment price target raised to 11,700 GBp at Citi
07/28/21 Peel Hunt
Flutter Entertainment upgraded to Buy from Reduce at Peel Hunt
07/27/21 JPMorgan
Flutter Entertainment upgraded to Overweight from Neutral at JPMorgan
07/22/21 RBC Capital
Flutter Entertainment upgraded to Outperform from Sector Perform at RBC Capital
WIMHY William Hill
$15.00 /

+ (+0.00%)

03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

07/28/21 Goldman Sachs
DraftKings price target lowered to $73 from $77 at Goldman Sachs
07/21/21 Needham
Needham sees NFT marketplace entrance as interesting call option for DraftKings
07/21/21 Craig-Hallum
Craig-Hallum bullish on DraftKings NFT marketplace, partnership with Autograph
06/25/21 Northland
DraftKings views risks in recent short report as 'irrelevant,' says Northland
WYNN Wynn Resorts
$102.16 /

+1.83 (+1.82%)

PENN Penn National
$72.06 /

+0.3 (+0.42%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

LVS Las Vegas Sands
$44.50 /

+0.88 (+2.02%)

GAN Gan Limited
$16.15 /

+0.39 (+2.47%)

DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

CZR Caesars
$92.54 /

+0.04 (+0.04%)

CHDN Churchill Downs
$188.06 /

-0.72 (-0.38%)

BYD Boyd Gaming
$58.55 /

+1.66 (+2.92%)

  • 09
    Feb
  • 17
    Dec
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
WYNN Wynn Resorts
$102.16 /

+1.83 (+1.82%)

PENN Penn National
$72.06 /

+0.3 (+0.42%)

PDYPY Flutter Entertainment
$88.34 /

+0.89 (+1.02%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

BYD Boyd Gaming
$58.55 /

+1.66 (+2.92%)

WIMHY William Hill
$15.00 /

+ (+0.00%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

LVS Las Vegas Sands
$44.50 /

+0.88 (+2.02%)

GAN Gan Limited
$16.15 /

+0.39 (+2.47%)

DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

CZR Caesars
$92.54 /

+0.04 (+0.04%)

CHDN Churchill Downs
$188.06 /

-0.72 (-0.38%)

BYD Boyd Gaming
$58.55 /

+1.66 (+2.92%)

WYNN Wynn Resorts
$102.16 /

+1.83 (+1.82%)

PENN Penn National
$72.06 /

+0.3 (+0.42%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

LVS Las Vegas Sands
$44.50 /

+0.88 (+2.02%)

GAN Gan Limited
$16.15 /

+0.39 (+2.47%)

DKNG DraftKings
$50.63 /

+1.87 (+3.84%)

CZR Caesars
$92.54 /

+0.04 (+0.04%)

Hot Stocks
Eli Lilly and Incyte's baricitinib granted broadened COVID emergency use by FDA » 09:29
07/29/21
07/29
09:29
07/29/21
09:29
LLY

Eli Lilly

$246.50 /

+3.11 (+1.28%)

, INCY

Incyte

$78.04 /

+1.71 (+2.24%)

Eli Lilly (LLY) and…

Eli Lilly (LLY) and Incyte (INCY) announced the FDA has broadened the Emergency Use Authorization for baricitinib to allow for treatment with or without remdesivir, whereas the EUA was previously restricted to use only in combination with remdesivir. The EUA now provides for the use of baricitinib for treatment of COVID-19 in hospitalized adults and pediatric patients two years of age or older requiring supplemental oxygen, non-invasive or invasive mechanical ventilation or extracorporeal membrane oxygenation. The FDA based the decision on data from the Phase 3 COV-BARRIER study, announced April 8. Baricitinib-treated patients were less likely than those receiving standard of care to progress to ventilation or death. A pre-specified key secondary endpoint showed baricitinib, in addition to standard of care, meaningfully reduced the risk of death by 39% by Day 28 when compared to standard of care alone.

ShowHide Related Items >><<
LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

INCY Incyte
$78.04 /

+1.71 (+2.24%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Stifel
Acumen initiated with a Buy at Stifel
07/19/21 Goldman Sachs
Option Care Health upgraded to Buy from Neutral at Goldman Sachs
INCY Incyte
$78.04 /

+1.71 (+2.24%)

07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
06/25/21 RBC Capital
Incyte price target lowered to $88 from $92 at RBC Capital
06/23/21 Benchmark
Incyte's retifanlimab does not seem likely to be approved, says Benchmark
02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

INCY Incyte
$78.04 /

+1.71 (+2.24%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

INCY Incyte
$78.04 /

+1.71 (+2.24%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

INCY Incyte
$78.04 /

+1.71 (+2.24%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

INCY Incyte
$78.04 /

+1.71 (+2.24%)

Hot Stocks
Loxo Oncology, Kumquat enter collaboration on novel small molecules » 08:31
07/29/21
07/29
08:31
07/29/21
08:31
LLY

Eli Lilly

$246.50 /

+3.11 (+1.28%)

Loxo Oncology, a research…

Loxo Oncology, a research and development group of Eli Lilly, and Kumquat Biosciences announced an exclusive collaboration focused on the discovery, development and commercialization of potential novel small molecules that stimulate tumor-specific immune responses. Through the multi-year collaboration, Kumquat will utilize its small molecule immuno-oncology, or IO, platform to discover novel clinical candidates and Lilly has the option to select a certain number of drug candidates for further development and commercialization worldwide, excluding Greater China. Kumquat has retained development and commercialization rights in Greater China for each of the drug candidates selected by Lilly, subject to Lilly's option to co-commercialize in Greater China. Additionally, Kumquat has the option to co-develop and co-commercialize a certain number of the drug candidates selected by Lilly in the U.S. Kumquat will receive an aggregate of $70M consisting of a cash upfront payment and an equity investment. Kumquat is eligible to receive over $2B in potential milestone payments based on the achievement of preclinical, development and future commercial milestones, as well as royalties on sales of commercialized products resulting from the collaboration.

ShowHide Related Items >><<
LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Truist
Eli Lilly assumed with a Buy at Truist
07/26/21 Stifel
Acumen initiated with a Buy at Stifel
07/19/21 Goldman Sachs
Option Care Health upgraded to Buy from Neutral at Goldman Sachs
LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

LLY Eli Lilly
$246.50 /

+3.11 (+1.28%)

Hot Stocks
Accenture acquires Openmind, terms undisclosed » 05:08
07/29/21
07/29
05:08
07/29/21
05:08
ACN

Accenture

$316.26 /

-3.59 (-1.12%)

Accenture has acquired…

Accenture has acquired Openmind, a commerce agency in Italy with capabilities in cloud-based platforms, to meet client demand in the growing commerce market and deliver experiences. Terms of the transaction were not disclosed. Founded in 2004, Openmind, based in Monza, Italy, works with some of the world's luxury and fashion brands. Approximately 110 employees from Openmind will join Accenture Interactive in Italy.

ShowHide Related Items >><<
ACN Accenture
$316.26 /

-3.59 (-1.12%)

ACN Accenture
$316.26 /

-3.59 (-1.12%)

07/26/21
Fly Intel: Top five analyst upgrades
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
07/26/21 Redburn
Accenture upgraded to Buy from Neutral at Redburn
06/29/21 Argus
Accenture price target raised to $330 from $300 at Argus
ACN Accenture
$316.26 /

-3.59 (-1.12%)

ACN Accenture
$316.26 /

-3.59 (-1.12%)

ACN Accenture
$316.26 /

-3.59 (-1.12%)

Wednesday
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:53
07/28/21
07/28
16:53
07/28/21
16:53
AAPL

Apple

$144.98 /

-1.8 (-1.23%)

, GOOG

Alphabet

$2,727.64 /

-4.57 (-0.17%)

, GOOGL

Alphabet Class A

$2,722.81 /

+84.175 (+3.19%)

, MSFT

Microsoft

$286.12 /

-0.77 (-0.27%)

, PFE

Pfizer

$43.45 /

+1.39 (+3.30%)

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$438.80 /

-0.1901 (-0.04%)

, TDOC

Teladoc

$152.12 /

+1.3 (+0.86%)

, MGM

MGM Resorts

$38.40 /

+0.37 (+0.97%)

, RMD

ResMed

$266.01 /

+1.61 (+0.61%)

, FLDM

Fluidigm

$7.10 /

+0.74 (+11.64%)

, CS

Credit Suisse

$10.28 /

+0.06 (+0.59%)

, TWTR

Twitter

$69.94 /

+1.62 (+2.37%)

, BAX

Baxter

$82.00 /

-0.13 (-0.16%)

, HRC

Hill-Rom

$132.69 /

+8.92 (+7.21%)

, GIW

GigInternational1

$9.82 /

-0.04 (-0.41%)

, ASXC

Asensus Surgical

$2.37 /

+0.22 (+10.23%)

, TEVA

Teva

$9.99 /

+1.075 (+12.06%)

, TLRY

Tilray

$16.00 /

+3.27 (+25.69%)

, HMLP

Hoegh LNG Partners

$6.30 /

-11.485 (-64.60%)

, CFG

Citizens Financial

$43.30 /

-1.025 (-2.31%)

, ISBC

Investors Bancorp

$14.43 /

+1.42 (+10.91%)

, CAKE

Cheesecake Factory

$47.76 /

-7.32 (-13.29%)

, MCD

McDonald's

$241.80 /

-5.06 (-2.05%)

, SPOT

Spotify

$223.37 /

-13.56 (-5.72%)

, SBUX

Starbucks

$122.49 /

-3.6 (-2.86%)

, MAT

Mattel

$21.55 /

+0.965 (+4.69%)

, BA

Boeing

$231.55 /

+9.35 (+4.21%)

, AMD

AMD

$97.88 /

+6.78 (+7.44%)

, V

Visa

$246.93 /

-3.99 (-1.59%)

, PHG

Philips

$45.49 /

-0.01 (-0.02%)

Get caught up quickly on…

ShowHide Related Items >><<
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

07/29/21 Craig-Hallum
Cirrus Logic upgraded to Buy at Craig-Hallum on results beat, Apple strength
07/29/21 KeyBanc
Cirrus Logic price target raised to $105 from $100 at KeyBanc
07/28/21 Loop Capital
Apple price target raised to $165 from $150 at Loop Capital
07/28/21 Wedbush
Apple delivers 'gold medal performance' for June, says Wedbush
GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

07/29/21 Wells Fargo
Facebook price target raised to $450 from $415 at Wells Fargo
07/29/21 Morgan Stanley
Facebook price target raised to $400 from $375 at Morgan Stanley
07/28/21 Wedbush
Alphabet price target raised to $3,424 from $3,127 at Wedbush
07/28/21 JPMorgan
Alphabet price target raised to $3,250 from $2,875 at JPMorgan
GOOGL Alphabet Class A
$2,722.81 /

+84.175 (+3.19%)

07/29/21 Argus
Alphabet price target raised to $3,100 from $2,800 at Argus
07/28/21 BMO Capital
Alphabet price target raised to $3,000 from $2,700 at BMO Capital
MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

07/28/21 JPMorgan
Microsoft price target raised to $310 from $300 at JPMorgan
07/28/21
Fly Intel: Top five analyst initiations
07/28/21 BMO Capital
Microsoft price target raised to $325 from $290 at BMO Capital
07/28/21 Wedbush
Wedbush bullish on Microsoft following 'robust' results, guidance
PFE Pfizer
$43.45 /

+1.39 (+3.30%)

07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/26/21 Truist
Pfizer assumed with a Buy at Truist
07/23/21 BMO Capital
Arvinas price target raised to $111 from $101 at BMO Capital
07/23/21 Citi
Arvinas price target raised to $153 from $118 at Citi
SPX S&P 500
/

+

03/15/21 Morgan Stanley
Morgan Stanley equity strategist downgrades small cap stocks
03/12/21
On The Fly: Weekly technical notes for S&P 500
01/07/21 Credit Suisse
Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside
11/09/20 JPMorgan
JPMorgan sees S&P 500 hitting 4,000 by early next year
SPY SPDR S&P 500 ETF Trust
$438.80 /

-0.1901 (-0.04%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

07/28/21
Fly Intel: Top five analyst downgrades
07/28/21 SVB Leerink
Teladoc price target lowered to $218 from $266 at SVB Leerink
07/28/21 BTIG
Teladoc price target lowered to $260 from $300 at BTIG
07/28/21 Craig-Hallum
Teladoc price target lowered to $165 from $202 at Craig-Hallum
MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

07/28/21
Fly Intel: Top five analyst upgrades
07/28/21 Goldman Sachs
MGM Resorts upgraded to Neutral from Sell at Goldman Sachs
06/24/21
Fly Intel: Top five analyst upgrades
06/24/21 Deutsche Bank
Deutsche upgrades MGM Resorts to Buy on margin upside potential
RMD ResMed
$266.01 /

+1.61 (+0.61%)

07/28/21 Jefferies
ResMed upgraded to Hold at Jefferies following survey on Philips recall
07/28/21 Jefferies
ResMed upgraded to Hold from Underperform at Jefferies
07/27/21 RBC Capital
ResMed price target raised to $238 from $223 at RBC Capital
FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

05/12/21 Piper Sandler
Fluidigm price target lowered to $7 from $8 at Piper Sandler
02/11/21 Piper Sandler
Fluidigm price target lowered to $8 from $15 at Piper Sandler
12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
11/09/20 Piper Sandler
Buy companies with COVID-19 tests on today's selloff, says Piper Sandler
CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

07/19/21 Barclays
Credit Suisse price target lowered to CHF 12 from CHF 12.50 at Barclays
07/15/21 Jefferies
Credit Suisse initiated with a Hold at Jefferies
07/13/21 Deutsche Bank
Credit Suisse price target lowered to CHF 11 from CHF 12 at Deutsche Bank
07/12/21 Morgan Stanley
Credit Suisse price target lowered to CHF 10 from CHF 11 at Morgan Stanley
TWTR Twitter
$69.94 /

+1.62 (+2.37%)

07/23/21 Jefferies
Twitter price target raised to $80 from $70 at Jefferies
07/23/21 Truist
Twitter price target raised to $80 from $70 at Truist
07/23/21 Oppenheimer
Twitter price target raised to $85 from $70 at Oppenheimer
BAX Baxter
$82.00 /

-0.13 (-0.16%)

07/29/21 KeyBanc
KeyBanc sees a potential acquisition of Hill-Rom 'favorably' for Baxter
07/28/21 KeyBanc
Baxter offer in $150-$165 range would be 'reasonable' for Hill-Rom, says KeyBanc
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Baxter initiated with an Equal Weight at Barclays
HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

05/03/21 Baird
Hill-Rom price target raised to $125 from $115 at Baird
02/08/21 Baird
Hill-Rom price target raised to $115 from $105 at Baird
GIW GigInternational1
$9.82 /

-0.04 (-0.41%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

05/26/21 H.C. Wainwright
Asensus Surgical initiated with a Buy at H.C. Wainwright
TEVA Teva
$9.99 /

+1.075 (+12.06%)

06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
TLRY Tilray
$16.00 /

+3.27 (+25.69%)

07/28/21 Roth Capital
Tilray positioned for further consolidation, says Roth Capital
06/30/21 MKM Partners
Tilray price target raised to $16 from $8.50 at MKM Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
06/23/21 Alliance Global Partners
Tilray price target lowered to $18 from $32 at Alliance Global Partners
HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 B. Riley
Hoegh LNG Partners downgraded to Neutral from Buy at B. Riley
07/28/21 Barclays
Hoegh LNG Partners downgraded to Underweight from Overweight at Barclays
CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

07/29/21 Janney Montgomery Scott
Investors Bancorp downgraded to Neutral from Buy at Janney Montgomery Scott
07/29/21 Keefe Bruyette
Investors Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
07/16/21 Citi
Citizens Financial assumed with a Neutral at Citi
07/06/21 Keefe Bruyette
Citizens Financial assumed with an Outperform at Keefe Bruyette
ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight on valuation at Stephens
05/05/21 Stephens
Investors Bancorp downgraded to Equal Weight from Overweight at Stephens
CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

07/12/21
Fly Intel: Top five analyst upgrades
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
07/12/21 Raymond James
Cheesecake Factory upgraded to Outperform from Market Perform at Raymond James
06/14/21 Wedbush
Cheesecake Factory added to 'Best Ideas List' at Wedbush
MCD McDonald's
$241.80 /

-5.06 (-2.05%)

07/29/21 Stephens
McDonald's price target raised to $260 from $245 at Stephens
07/29/21 Baird
McDonald's price target raised to $262 from $252 at Baird
07/29/21 Argus
McDonald's price target raised to $275 from $260 at Argus
07/29/21 Deutsche Bank
McDonald's price target raised to $264 from $253 at Deutsche Bank
SPOT Spotify
$223.37 /

-13.56 (-5.72%)

07/29/21 Credit Suisse
Spotify price target lowered to $270 from $315 at Credit Suisse
07/29/21 UBS
Spotify upgraded to Neutral from Sell at UBS
07/29/21 Guggenheim
Spotify upgraded to Buy at Guggenheim following nearly 40% pullback
07/29/21 Guggenheim
Spotify upgraded to Buy from Neutral at Guggenheim
SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

07/28/21 MKM Partners
Starbucks price target raised to $132 from $125 at MKM Partners
07/28/21 BMO Capital
Starbucks price target raised to $140 from $125 at BMO Capital
07/28/21 Barclays
Starbucks price target raised to $145 from $140 at Barclays
07/28/21 Piper Sandler
Starbucks price target raised to $108 from $104 at Piper Sandler
MAT Mattel
$21.55 /

+0.965 (+4.69%)

07/28/21 JPMorgan
Mattel price target raised to $28 from $27 at JPMorgan
07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
06/17/21 JPMorgan
Mattel's 'fast entry' into NFT testament to evolution, says JPMorgan
04/26/21 BMO Capital
Mattel price target raised to $30 from $26 at BMO Capital
BA Boeing
$231.55 /

+9.35 (+4.21%)

07/29/21 Susquehanna
Boeing estimates raised following earnings beat at Susquehanna
07/14/21 Morgan Stanley
Boeing's 787 'minor headache' doesn't change thesis, says Morgan Stanley
07/13/21
Fly Intel: Top five analyst upgrades
07/13/21 Wolfe Research
Boeing upgraded to Peer Perform at Wolfe Research after United's big order
AMD AMD
$97.88 /

+6.78 (+7.44%)

07/29/21 BMO Capital
Xilinx price target raised to $140 from $130 at BMO Capital
07/29/21 Argus
AMD price target raised to $120 from $106 at Argus
07/28/21 Jefferies
AMD remains a top pick at Jefferies, sees server share gains to accelerate
07/28/21 Northland
AMD price target raised to $125 from $116 at Northland
V Visa
$246.93 /

-3.99 (-1.59%)

07/28/21 Wedbush
Visa price target raised to $270 from $250 at Wedbush
07/28/21 Compass Point
Visa price target raised to $290 from $265 at Compass Point
07/28/21 Wells Fargo
Visa price target raised to $280 from $265 at Wells Fargo
07/28/21 Susquehanna
Visa price target raised to $290 from $265 at Susquehanna
PHG Philips
$45.49 /

-0.01 (-0.02%)

07/28/21 UBS
Philips price target lowered to EUR 53 from EUR 56 at UBS
07/28/21 Deutsche Bank
Philips price target lowered to EUR 43 from EUR 44 at Deutsche Bank
07/28/21 BofA
Philips downgraded to Neutral from Buy at BofA
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

RMD ResMed
$266.01 /

+1.61 (+0.61%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

ISBC Investors Bancorp
$14.43 /

+1.42 (+10.91%)

HRC Hill-Rom
$132.69 /

+8.92 (+7.21%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

  • 11
    Jun
  • 13
    Oct
V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

GIW GigInternational1
$9.82 /

-0.04 (-0.41%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

BAX Baxter
$82.00 /

-0.13 (-0.16%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

V Visa
$246.93 /

-3.99 (-1.59%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

PHG Philips
$45.49 /

-0.01 (-0.02%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

MAT Mattel
$21.55 /

+0.965 (+4.69%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

FLDM Fluidigm
$7.10 /

+0.74 (+11.64%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

CAKE Cheesecake Factory
$47.76 /

-7.32 (-13.29%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

V Visa
$246.93 /

-3.99 (-1.59%)

TWTR Twitter
$69.94 /

+1.62 (+2.37%)

TLRY Tilray
$16.00 /

+3.27 (+25.69%)

TEVA Teva
$9.99 /

+1.075 (+12.06%)

TDOC Teladoc
$152.12 /

+1.3 (+0.86%)

SPX S&P 500
/

+

SPOT Spotify
$223.37 /

-13.56 (-5.72%)

SBUX Starbucks
$122.49 /

-3.6 (-2.86%)

RMD ResMed
$266.01 /

+1.61 (+0.61%)

PFE Pfizer
$43.45 /

+1.39 (+3.30%)

MSFT Microsoft
$286.12 /

-0.77 (-0.27%)

MGM MGM Resorts
$38.40 /

+0.37 (+0.97%)

MCD McDonald's
$241.80 /

-5.06 (-2.05%)

HMLP Hoegh LNG Partners
$6.30 /

-11.485 (-64.60%)

GOOGL Alphabet Class A
$2,722.81 /

+84.175 (+3.19%)

GOOG Alphabet
$2,727.64 /

-4.57 (-0.17%)

CS Credit Suisse
$10.28 /

+0.06 (+0.59%)

CFG Citizens Financial
$43.30 /

-1.025 (-2.31%)

BA Boeing
$231.55 /

+9.35 (+4.21%)

ASXC Asensus Surgical
$2.37 /

+0.22 (+10.23%)

AMD AMD
$97.88 /

+6.78 (+7.44%)

AAPL Apple
$144.98 /

-1.8 (-1.23%)

SPY SPDR S&P 500 ETF Trust
$438.80 /

-0.1901 (-0.04%)

SPX S&P 500
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.